Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

Kurume University Hospital, Kurume

Gunma Prefectural Cancer Center, Ōta

Asahikawa Medical University Hospital, Asahikawa

Iwamizawa Municipal General Hospital, Iwamizawa

Kobe University Hospital, Kobe

University Hospital,Kyoto Prefectural University of Medicine, Kamigyō-ku

Kindai University Hospital, Sayama

Osaka University Hospital, Suita

Osaka Medical and Pharmaceutical University Hospital, Takatsuki

Jichi Medical University Saitama Medical Center, Saitama

Hiroshima University Hospital, Hiroshima

Osaka City University Hospital, Osaka